Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Imaging of Primary Amyloid Cardiomyopathy — Stella

Home/Amyloidosis, Primary/Molecular Imaging of Primary Amyloid Cardiomyopathy

View on ClinicalTrials.gov

Recruiting

Back to Amyloidosis, Primary trials

Molecular Imaging of Primary Amyloid Cardiomyopathy

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Brigham and Womens' Hospital, Boston, Massachusetts

Key details

Sponsor

Brigham and Women's Hospital

Collaborators

National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~171 participants

Started

April 2016

Primary completion

December 2027

Age range

18 Years – 99 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.